Revance Therapeutics, Inc. – ‘S-3’ on 3/4/15 – EX-23.1

On:  Wednesday, 3/4/15, at 5:16pm ET   ·   Accession #:  1628280-15-1464   ·   File #:  333-202494

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Registration Statement for Securities Offered Pursuant to a Transaction   —   Form S-3
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3         Registration Statement for Securities Offered       HTML    324K 
                          Pursuant to a Transaction                              
 2: EX-4.5      Instrument Defining the Rights of Security Holders  HTML    255K 
 3: EX-4.6      Instrument Defining the Rights of Security Holders  HTML     90K 
 4: EX-4.7      Instrument Defining the Rights of Security Holders  HTML     91K 
 5: EX-4.8      Instrument Defining the Rights of Security Holders  HTML     80K 
 6: EX-5.1      Opinion re: Legality                                HTML     27K 
 7: EX-12.1     Statement re: Computation of Ratios                 HTML     21K 
 8: EX-23.1     Consent of Experts or Counsel                       HTML      7K 

EX-23.1   —   Consent of Experts or Counsel

This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-3’ Filing		Date		Other Filings
Filed on:		3/4/15		10-K
		12/31/14		10-K
				List all Filings